Excellent results. Great products and good to see the concentration on the technical/engineering end of the market.
The infrastructure spend is only increasing and if there are any bumps in the road this is a good space to be.
Good growth for a number of years ahead.
- Forums
- ASX - By Stock
- ACF
- Ann: Appendix 4E - Preliminary Final Report
ACF
acrow limited
Add to My Watchlist
1.52%
!
$1.01

Ann: Appendix 4E - Preliminary Final Report, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.01 |
Change
0.015(1.52%) |
Mkt cap ! $306.4M |
Open | High | Low | Value | Volume |
99.0¢ | $1.02 | 99.0¢ | $440.8K | 440.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11100 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 1717 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13645 | 0.995 |
3 | 14215 | 0.990 |
2 | 6934 | 0.985 |
2 | 18150 | 0.980 |
3 | 28544 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 7292 | 3 |
1.010 | 14958 | 1 |
1.015 | 5320 | 3 |
1.020 | 27746 | 5 |
1.030 | 9784 | 1 |
Last trade - 15.56pm 04/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online